Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CHF | +3.45% | -0.33% | +30.43% |
Jun. 06 | Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024 | |
Jun. 06 | Addex Therapeutics' Q1 Net Loss Widens; Revenue Down | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.43% | 6.57M | |
+21.85% | 46.44B | |
+37.63% | 39.1B | |
-8.05% | 38.76B | |
+29.04% | 31.24B | |
-13.75% | 25.8B | |
+10.65% | 25.9B | |
+38.43% | 13.12B | |
-6.92% | 11.32B | |
-12.29% | 10.68B |
- Stock Market
- Equities
- ADXN Stock
- News Addex Therapeutics Ltd
- HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy Rating